TCL Archive ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer. March 24, 2006
TCL Archive In Brief: Breast Cancer coalition Plan Rally, Conference; FDA Seeks Information On Unlabeled Drug Uses April 30, 1993
TCL Archive Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks July 25, 2014
TCL Archive Women’s Health Trial Not Dead; Pls Say They’ll Improve Protocol, Make New Plans For Full Implementation January 29, 1988
